Sponsored Links
Lymphoma Information Network » Lymphoma Info » Lymphoma Prognosis

Lymphoma Prognosis

patient examination
photo by Tomasz Kobosz

To determine your prognosis, you need to gather information about the type of lymphoma. There are more than 35 types of lymphomas, including 5 types of Hodgkin's Lymphoma and 30 types of Non-Hodgkin's Lymphoma. Hodgkin Lymphomas generally have a higher survival rate than NHL.

Indolent or Aggressive?

You also need to know if you have an indolent, or slow-growing cancer or an aggressive one. Aggressive cancers are generally harder to treat and have a poorer prognosis.

In recent years, lymphoma treatments have improved immensely, resulting in better prognoses for patients. Lymphoma survival rates depend on several things, including:

  • Type of lymphoma (Non-Hodgkin's or Hodgkins, indolent or aggressive)
  • Stage of the disease
  • Age at diagnosis
  • Prior or existing health problems

Staging

The staging of the disease is also important. Early stages (stage I and II) of the disease are usually indicated by involvement of only one or two groups of lymph nodes. Later stages (Stage III and IV) are marked by involvement of the internal organs, including the bone marrow and blood. In general, the earlier the stage of the cancer, the higher the survival rate.

Sponsored Links

Some cancers are also graded by the presence of specific symptoms. A patient suffering from night sweats, fever, and weight loss has a slightly lower chance or survival than an asymptomatic one. Other cancers are graded by the size of affected cells, with smaller cells promising a better outcome, usually.

The age of the patient is also important. Younger patients have a better prognosis, with some five-year survival rates as high as 95%. In most cases, survival rates are also better for women than for men, so the sex of the patient is important when determining prognosis.

Finally, the health of the patient is a determining factor. If the patient was relatively healthy – meaning he or she isn't suffering from another disease upon diagnosis – then the prognosis is better. Patients suffering from other conditions or those who have relapsed from previous treatment have a worse prognosis.

Resources and Treatment Options

Please visit the sites of cancer organizations or government websites like the SEER Stat Sheet Website for more information.

Sponsored Links

Pharmatech Oncology assists lymphoma patients in identifying clinical studies. Follow this link to identify a conveniently located cancer treatment center and begin the process of enrollment.

Treatment and outcome can vary between types.If you are looking for some assistance with treatment options, there is an online tool available to help you understand treatment options and possible side effects. Click here to sign up for FREE.

Radioimmunotherapy is the latest type of cancer treatment to emerge from clinical studies. Learn more about the Zevalin regimen for some types of NHL.

Dive Deeper

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Featured Treatment
searching for treatment

Featured Treatment: Zevalin®

Zevalin® (Ibritumomab tiuxetan) is a form of radioimmunotherapy (a radiolabeled monoclonal antibody) for treatment of patients with relapsed or refractory, low‑grade or follicular B‑cell non‑Hodgkin's lymphoma (NHL). "Refractory" refers to a disease that does not respond to treatment.

Zevalin is the first radioummunotherapy treatment to be FDA-approved as a first-line therapy for lymphoma. Read more...

Sponsored Links
User login
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Poll
What is most important to you in an Online Support Group?:
Latest Blog Entries
Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.